| PERIOD ENDING | 28-Aug-09 | 29-May-09 | 28-Feb-09 | 28-Nov-08 | | Total Revenue | 356,350 | 412,922 | 422,519 | 454,084 | | Cost of Revenue | 153,248 | 167,169 | 223,288 | 223,214 | | | Gross Profit | 203,102 | 245,753 | 199,231 | 230,870 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 138,241 | 223,141 | 210,900 | 210,169 | | Non Recurring | 26,376 |
-
| 45,881 | 242,889 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 38,485 | 22,612 | (57,550) | (222,188) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,280 | 1,318 | (4,436) | 155 | | Earnings Before Interest And Taxes | 40,765 | 23,930 | (61,986) | (222,033) | | Interest Expense | 6,671 | 6,987 | 5,881 | 6,634 | | Income Before Tax | 34,094 | 16,943 | (67,867) | (228,667) | | Income Tax Expense | 10,972 | 6,982 | (17,789) | (35,356) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23,122 | 9,961 | (50,078) | (193,311) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,122 | 9,961 | (50,078) | (193,311) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,122 | $9,961 | ($50,078) | ($193,311) |
|
0.22% Nasdaq 0.00%
Income Statement
